AcelRx Pharma (ACRX)

4.15 -0.03 (0.72%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/1/18 *Est.)

Latest Headlines

Form 8-K ACELRX PHARMACEUTICALS For: Jun 14 June 15, 2018 6:07 AM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: ADAMS ADRIAN June 14, 2018 6:19 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: Afable Richard June 14, 2018 6:19 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: HOFFMAN C STEVEN June 14, 2018 6:17 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: EDWARDS MARK G June 14, 2018 6:15 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: Rosen Howard B June 14, 2018 6:14 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Jun 14 Filed by: WAN MARK A June 14, 2018 6:12 PM - SEC Filing Pre-Open Movers 06/12: (GLMD) (RH) (PLAY) Higher; (IDRA) (JCAP) (IMMU) Lower (more...) June 12, 2018 9:26 AM - StreetInsider After-Hours Stock Movers 06/11: (RH) (PLAY) (PFNX) Higher; (JCAP) (IMMU) (HOME) Lower (more...) June 11, 2018 5:27 PM - StreetInsider UPDATE: Cantor Fitzgerald Starts AcelRx Pharmaceuticals (ACRX) at Overweight June 11, 2018 4:08 PM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Jun 01 Filed by: EDWARDS MARK G June 5, 2018 5:53 PM - SEC Filing Form SC 13G ACELRX PHARMACEUTICALS Filed by: LEERINK REVELATION HEALTHCARE FUND I, L.P. May 31, 2018 11:18 AM - SEC Filing Form SC 13G ACELRX PHARMACEUTICALS Filed by: Industry Ventures Secondary VIII, L.P. May 31, 2018 11:16 AM - SEC Filing AcelRx Pharmaceuticals (ACRX) PT Raised to $7 at H.C. Wainwright May 29, 2018 7:17 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: May 25 Filed by: ASADORIAN RAFFI May 29, 2018 6:52 AM - SEC Filing Pre-Open Movers 05/24: (BW) (SMRT) (WSM) Higher; (REPH) (QUIK) (MLNT) Lower (more...) May 24, 2018 9:23 AM - StreetInsider AcelRx Pharma (ACRX) Says FDA Accepts NDA for DSUVIA; 11/3 PDUFA May 24, 2018 7:06 AM - StreetInsider AcelRx announces FDA acceptance of NDA for DSUVIA May 24, 2018 7:00 AM - PR NewsWire Form SC 13D/A ACELRX PHARMACEUTICALS Filed by: THREE ARCH PARTNERS IV LP May 24, 2018 6:06 AM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: May 21 Filed by: THREE ARCH ASSOCIATES III LP May 23, 2018 6:01 PM - SEC Filing Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures May 23, 2018 7:00 AM - PR NewsWire AcelRx Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference May 22, 2018 11:45 AM - PR NewsWire Form 10-Q ACELRX PHARMACEUTICALS For: Mar 31 May 10, 2018 6:11 AM - SEC Filing AcelRx Pharma (ACRX) Reports Q1 Loss of $0.23 May 9, 2018 4:11 PM - StreetInsider AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results May 9, 2018 4:05 PM - PR NewsWire AcelRx Pharma (ACRX) Resubmits NDA for DSUVIA May 9, 2018 7:26 AM - StreetInsider AcelRx resubmits New Drug Application for DSUVIA™ May 9, 2018 7:00 AM - PR NewsWire AcelRx Pharmaceuticals Reports Publication Analyzing Errors Associated with Existing IV Patient-Controlled Analgesia Systems April 30, 2018 7:00 AM - PR NewsWire AcelRx Pharma (ACRX) Receives Positive CHMP Opinion for DZUVEO for Management of Pain April 27, 2018 7:21 AM - StreetInsider AcelRx receives positive CHMP opinion for DZUVEO™ for management of acute moderate to severe pain in medically monitored settings April 27, 2018 7:20 AM - PR NewsWire AcelRx to announce first quarter 2018 results and provide a corporate update on Wednesday, May 9th, 2018 April 25, 2018 4:30 PM - PR NewsWire Form DEFA14A ACELRX PHARMACEUTICALS April 23, 2018 5:11 PM - SEC Filing Form DEF 14A ACELRX PHARMACEUTICALS For: Jun 14 April 23, 2018 5:09 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Apr 16 Filed by: Saia John G. April 18, 2018 5:08 PM - SEC Filing Form 3 ACELRX PHARMACEUTICALS For: Apr 16 Filed by: Saia John G. April 18, 2018 5:06 PM - SEC Filing AcelRx Pharma (ACRX) Says Publication Concludes Sublingual Sufentanil Tablets Provide Opportunity to Non-Invasively and Rapidly Treat Moderate-To-Severe Acute Pain April 18, 2018 7:02 AM - StreetInsider AcelRx Pharmaceuticals Announces Publication Concluding that Sublingual Sufentanil Tablets Provide the Opportunity to Non-Invasively and Rapidly Treat Moderate-To-Severe Acute Pain in a Monitored Sett April 18, 2018 7:00 AM - PR NewsWire Pre-Open Stock Movers 04/16: (ERI) (ALKS) (DVAX) Higher; (CLDX) (ALGT) (NLNK) Lower (more...) April 16, 2018 9:23 AM - StreetInsider AcelRx Pharma (ACRX) Completes Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 April 16, 2018 7:09 AM - StreetInsider AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018 April 16, 2018 7:00 AM - PR NewsWire Form 8-K ACELRX PHARMACEUTICALS For: Apr 07 April 12, 2018 4:31 PM - SEC Filing AcelRx Announces Publication Analyzing the Cost of Administering IV Morphine for Acute Pain in Emergency Departments in Europe April 11, 2018 9:15 AM - PR NewsWire Form 8-K ACELRX PHARMACEUTICALS For: Mar 27 March 27, 2018 7:07 AM - SEC Filing AcelRx announces appointment of John Saia as General Counsel March 27, 2018 7:00 AM - PR NewsWire Full Article List